News

BENGALURU (Reuters) -Pressured by U.S. tariffs and foreign investor outflows, India's stock markets will manage to eke out ...
Participants Who Complete Treatment in Global Phase 2b PRIZM MELAS Study Are Eligible to EnrollCAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the first ...